Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Pulmonology > Obstructive Lung Disease > Flashcards

Obstructive Lung Disease Flashcards

1
Q

Extrinsic Asthma

A

Initiated by Type 1 hypersensitivity reaction induced by exposure to an outside agent

I.e. Allergic asthma, occupational asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Intrinsic Asthma

A

Initiated by non-immune mechanisms, i.e. inhaled irritants, exercise, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Inflammatory cells present in asthma

A

Mast cells - activated by allergen via IgE receptors; release histamine

Eosinophils - release proteins that damage epithelial cells

Macrophages - activated by allergens to release cytokines

Neutrophils - present in airways and sputum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Structural changes in airways - asthma

A

Increased smooth muscle proliferation
Blood vessel proliferation
Mucus hyper-secretion

Final common pathway is airway narrowing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Asthma LFTs

A

Decreased FEV1/FVC - reversible or improved with a beta-adrenergic agonist, defined as improvement of > 12% or an absolute increase of > 200 mL

TLC, RV, FRC increased due to air-trapping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Methacholine challenge

A

Patient performs serial spirometry after inhaling progressively larger concentrations of bronchoconstrictor, stimulating airway obstruction

Asthmatics require less methacholine to reduce FEV1 by 20% (lower PC20)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Asthma treatments to reduce airway tone

A

Beta agonists - short acting (albuterol) vs. long acting

Anti-cholinergics (Ipratropium) - reduce vasoconstriction

Leukotriene inhibitors - reduce vasoconstriction

Phosphodiesterase inhibitors - increase intracellular cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Asthma treatments to reduce inflammation

A

Corticosteroids - reduce # of inflammatory cells, decrease airway edema

Mast cell stabilizers

Anti-IgE therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Definition of COPD

A

Irreversible airflow limitation (FEV1/FVC < 0.70)

Includes elements of chronic bronchitis and emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GOLD I

A

Mild COPD, defined as FEV1/FVC < 0.70

AND

FEV1 < 80% predicted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GOLD II

A

Moderate COPD, defined as FEV1/FVC < 0.70

AND

FEV1 50-70% predicted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

GOLD III

A

Severe COPD, defined as FEV1/FEV < 0.70

AND

FEV1 30-50% predicted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Gold IV

A

Very severe COPD, defined as FEV1/FEV < 0.70

AND

FEV1 < 30% Predicted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Chronic Bronchitis - Definition

A

Productive cough present for 3 months/year over a 2-year period without another identified medical cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Histologic changes in chronic bronchitis

A

Hypertrophy of submucosal glands
Increased number of goblet cells
Increase in size and number of smooth muscle cells
Squamous metaplasia

Final common pathway is narrowing of the airway lumen and obstruction by mucus with increased airflow resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Emphysema - Definition

A

Abnormal, permanent enlargement of alveoli with destruction of alveolar septa; leads to increased lung compliance with loss of elastic recoil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Centriacinar Emphysema

A

Scarring and dilation of the respiratory bronchioles and adjacent alveoli, resulting in the development of pathologically enlarged air spaces

Most often associated with smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Panacinar Emphysema

A

Scarring and dilation of the entire respiratory bronchiole + alveolar unit

More commonly seen in alpha-1-anti-trypsin deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

PFTs in COPD

A

Decreased FEV1/FVC (< 0.70)
Increased RV/FRC/TLC due to hyperinflation
Reduced DLCO due to destruction of the air-blood barrier (emphysema only)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Bronchiectasis

A

Abnormal dilation of the proximal, medium-sized bronchi due to destruction of the muscular and elastic components of their walls; requires infectious/inflammatory insult + impaired drainage leading to sustained tissue damage

Dilated airways are collapsible, resulting in obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cystic Fibrosis - Genetics & Clinical Characteristics

A

Autosomal recessive mutation in the CFTR gene, resulting in dysfunctional chloride secretion across epithelial surfaces

Major clinical complications: recurrent sinus and pulmonary infections with resultant bronchiectasis and airway obstruction; pancreatic insufficiency and pancreatitis, male infertility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Ivacaftor

A

Targeted genetic therapy for CF aptients with G551D mutation in the CFTR gene (4% of CF patients); restores function of the mutant CF protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Treatment strategies for CF

A 
Antibiotics to treat recurrent infections
Bronchodilators
Nebulized hypertonic saline 
Chest physiotherapy
Lung transplantation
24
Q

Bronchiolitis obliterans - adults

A

Inflammation of the bronchioles (<2mm)

In adults, most commonly caused by inhalation of toxic gases, autoimmune pathology, or drugs in adults (rarely infectious)

25
Bronchiolitis - Kids
Inflammation of the bronchioles (< 2mm) more often infectious in etiology (i.e. RSV)
26
What is the characteristic physical exam finding of bronchiolitis?
Inspiratory squeaks
27
Well-controlled asthma
``` Symptoms no more than 2x/week Nighttime symptoms no more than 2x/month SABA used < 2x/week Oral steroid use no more than 1x/year Urgent care visit no more than 1x/year ```
28
Inhaled glucocorticoids
Preferred long-term control medication for persistent asthma Dose should be reduced 20-50% every 3 months to achieve lowest dose possible while maintaining contol
29
Short-acting Beta-2 agonist
Smooth muscle relaxation via stimulation of B-2 receptors causes bronchodilation Rapid onset of action within minutes; lasts 4-6 hours
30
Long-acting Beta-2 agonists
Used prophylactically to prevent symptoms; effect lasts 12 hours Black box warning - observed increase in asthma-related deaths; should not be used as monotherapy
31
Leukotriene modifers
Direct leukotriene antagonist OR 5-lipoxygenase inhibitor Causes bronchodilation and reduces inflammation Administered orally
32
Anti-IgE therapy
Binds to IgE, inhibiting its binding to mast cells Parenteral administratio (IV, SC) Adverse effects: Anaphylaxis For treatment of allergic asthma
33
Anticholinergics
Ex: Tiotroprium, Atropine Inhibit bronchoconstricting effects of ACh on muscarinic receptors on bronchial smooth muscle Long acting anti-cholinergics are approved for COPD (not asthma)
34
Therapeutic options for COPD
``` Beta agonists (short or long acting) Anti-cholinergics (short or long acting) Inhaled corticosteroids ```
35
Pathology - Acute vs. Chronic Bronchitis
Acute bronchitis - neutrophils & mucous in the airway lumen and infiltrating vessel wall; usually infectious Chronic bronchitis - mostly lymphocytes infiltrating airway wall; may be accompanied by squamous metaplasia of the epithelium and mucous gland hypertrophy
36
Bronchiectasis - Pathology
Dilation of the medium-sized airway compared to the neighboring vessel Leads to mucus plugging & recurrent infectious because airways cannot clear mucous effectively
37
Follicular bronchiolitis - Pathology
Characterized by the presence of ectopic germinal center comprised mostly of B-cells within the bronchiole Associated with CVD, immunodeficiency
38
Constrictive and Obltierative Bronchiolitis (Bronchiolitis Obliterans) - Pathology
Inflammation and fibrosis of the bronchioles resulting in scarring of the bronchiole airway closed Lesions are focal, blocking off one airway so that the lobule of lung distal to that airway becomes "air trapped"
39
Granulomatous bronchiolitis - Pathology
Presence of multinucleated giant cells & activated macrophages May be infectious (TB, fungal) or non-necrotizing (sarcoid, beryllium)
40
Main histologic changes associated with asthma (4)
1. Thickening of the basal lamina underlying the epithelium 2. Eosinophilic inflammation 3. Mucus hypersecretion 4. Smooth muscle hyperplasia surrounding the airway
41
Emphysema - Pathology
Broken alveolar septa - air spaces enlarge and form "cysts" "Flag sign" refers to the "rolled up" appearance of broken septae Subpleural blebs - may cause pneumothorax if ruptured
42
Smoking vs. anti-trypsin emphysema - Pathology
Smoking-related emphysema is worse in the upper lobes and around airways (centrilobular) Alpha-1-antitrypsin deficiency-related emphysema is worse in the lower lobes and involves the entire gas exchange unit (panlobular)
43
3 major determinants of site and severity of occupational lung disease
Dose of chemical ( = duration of exposure x concentration) Solubility of chemical - more water-soluble agents deposit in the upper airway; less water-soluble agents affect the distal airways/bronchioles Particle size - > 10 microns are filtered in the upper airway; < 10 microns are "respirable" and penetrate more deeply into the lung
44
Occupational (Immunologic) asthma - Definition & Prevalence
Characterized by variable airflow obstruction, airway hyperresponsiveness, and airway inflammation attributable to a particular occupational exposure which triggers an IgE-mediated immunologic reaction Presents with latency - months to years after initial exposure; often displays a temporal pattern of symptosm Accounts for up to 15% of adult asthma
45
Irritant Asthma (Reactive airways dysfunction syndrome, RADS)
Direct airway epithelial injury caused by inhalation of substances with irritant properties, leading to persistent hyperresponsiveness and airflow obstruction Presents without latency - symptom onset is clasically 24-48 hours after exposure
46
Occupational COPD
Accounts for 15% of COPD Most often associated with coal mine dust, respirable silica, and biomass combustion
47
Constrictive / Obliterative Bronchiolitis
Injury of the small airways with resultant scarring and fibrosis of the airways closed Often associated with toxic exposure, i.e. diacetyl flavoring on buttered popcorn
48
4 airway diseases associated with environmental exposures
Occupational (Immunologic) asthma Irritant asthma (Reactive Airways Dysfunction Syndrome ) Chronic Obstructive Pulmonary Disease Constrictive / Obliterative Bronchiolitis
49
Triggers of occupational asthma
HMW compounds - animal proteins, baking flours LMW compouns - isosianaids, epoxy resins
50
Triggers of irritant asthma / RADS
Noxious irritant gas/vapor/dust Think 9/11
51
LABA - Example & Uses
Salmeterol Used in asthma & COPD Never used as monotherapy; combination therapy only!
52
Anti-cholinergics - Examples & Uses
Atropine, Tiotropium, Ipratropium Approved for COPD but not asthma
53
Systemic corticosteroids - examples & uses
Prednisone - oral or IV Used to treat acute exacerbations of asthma
54
Inhaled corticosteroids - examples & uses
Beclomethasone diproprionate, triamcinolone, acetonide Preferred long-acting control agent to treat asthma and COPD
55
Immunomodulation therapy for asthma
Omalizumab - SC Anti-IgE approve for allergic asthma

Pulmonology (15 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions